XML 137 R30.htm IDEA: XBRL DOCUMENT v3.25.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2024
Share-Based Compensation [Abstract]  
Schedule of Share-Based Compensation Expense

The Company recorded share-based compensation expense in the following expense categories of its accompanying consolidated statements of operations:

 

Year Ended
December 31,

   

2024

 

2023

General and administrative

 

$

1,303,546

 

$

52,000

Research and development

 

 

20,390

 

 

Total share-based compensation

 

$

1,323,936

 

$

52,000

Schedule of Option Activity

The following table summarizes option activity for the year ended December 31, 2024:

 

Options

 

Weighted
Average
Exercise Price

 

Weighted
Average
Remaining Life
(Years)

Balance at January 1, 2024

 

1,335,078

 

 

$

0.23

 

5.83

Granted

 

1,371,415

 

 

 

10.23

   

Exercised

 

(160,991

)

 

 

0.48

   

Forfeited

 

(7,900

)

 

 

10.23

   

Balance at December 31, 2024

 

2,537,602

 

 

$

5.60

 

7.85

Vested and expected to vest

 

2,537,602

 

 

$

5.60

 

7.85

Exercisable at the end of the period

 

1,174,087

 

 

$

0.19

 

5.90

Schedule of Options Granted

The following tables provide additional detail about the options granted during the year ended December 31, 2024:

Employees

Grant Date

 

NSO
Options
(1)
(#)

 

Exercise
Price
($)

June 6, 2024

 

651,737

(3)

 

10.23

September 9, 2024(2)

 

177,747

 

 

10.23

(1)      One-fourth of the total number of shares of Class A common stock subject to the NSOs vest and become exercisable on June 6, 2025, and one-sixteenth of the total number of shares of Class A common stock subject to the Option shall vest and become exercisable on each three (3)-month anniversary thereafter, subject to the applicable employee’s continued service through the applicable vesting date

(2)      The vesting commencement date for NSOs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.

(3)      7,900 options were forfeited during the year ended December 31, 2024 which resulted in a reversal of share-based compensation expense of $2,667 as the Company accounts for forfeitures as they occur.

Non-employee Directors

Grant Date

 

NSO
Options
(1)
(#)

 

Exercise
Price
($)

June 6, 2024

 

99,540

 

10.23

(1)      These NSOs vest and become exercisable in full on the earlier of (i) the one year anniversary of the grant date and (ii) the date of the next annual shareholders’ meeting of the Company following the grant date, subject to the applicable non-employee director’s continued service through the applicable vesting date.

Non-employee Equity Method Investees

Grant Date

 

NSO
Options
(1)
(#)

 

Exercise
Price
($)

June 6, 2024

 

65,832

 

10.23

September 9, 2024(2)

 

376,560

 

10.23

(1)      One-fourth of the total number of shares of Class A common stock subject to the NSOs vest and become exercisable on June 6, 2025, and one-sixteenth of the total number of shares of Class A common stock subject to the Option shall vest and become exercisable on each three (3)-month anniversary thereafter, subject to the applicable recipient’s continued service through the applicable vesting date

(2)      The vesting commencement date for NSOs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.

Schedule of Fair Value of NSOs Determined Using Black-Scholes Option-Pricing Model

The fair value of the NSOs were determined using the Black-Scholes option-pricing model and were based on the following weighted average assumptions:

 

Grant Date

Incentive Plan

 

June 6,
2024

 

September 9,
2024

Expected term – years

 

6.1

 

 

10.0

 

Expected volatility

 

29.5

%

 

28.5

%

Risk-free interest rate

 

4.2

%

 

3.7

%

Expected dividends

 

 

 

 

Schedule of RSU Activity

The following table summarizes RSU activity for the year ended December 31, 2024:

 

Awards

 

Weighted
Average
Grant Date
Fair Value

Balance at January 1, 2024

 

 

 

$

Granted

 

523,300

 

 

 

8.15

Vested

 

 

 

 

Forfeited

 

(3,000

)

 

 

10.23

Balance at December 31, 2024

 

520,300

 

 

$

8.13

Schedule of RSUs granted

The following tables provide additional detail about the RSUs granted during the year ended December 31, 2024:

Employees

Grant Date

 

Awards(1)
(#)

 

Grant Date
Fair Value
($)

June 6, 2024

 

247,500

(3)

 

10.23

September 9, 2024(2)

 

70,000

 

 

5.11

(1)      These awards vest as to 25% of the total awards granted on each of the first four anniversaries of the applicable vesting commencement date, subject to the applicable employee’s continued service through the applicable vesting date.

(2)      The vesting commencement date for RSUs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.

(3)      3,000 awards were forfeited during the year ended December 31, 2024 which resulted in a reversal of share-based compensation expense of $2,666 as the Company accounts for forfeitures as they occur.

Non-employee Directors

Grant Date

 

Awards(1)
(#)

 

Grant Date
Fair Value
($)

June 6, 2024

 

37,800

 

10.23

(1)      These awards vest in full on the earlier of (i) the one (1) year anniversary of the grant date and (ii) the date of the next annual shareholders’ meeting of the Company following the grant date, subject to the applicable non-employee director’s continued service through the applicable vesting date.

Non-employee Equity Method Investees

Grant Date

 

Awards(1)
(#)

 

Grant Date
Fair Value
($)

June 6, 2024

 

25,000

 

10.23

September 9, 2024(2)

 

143,000

 

5.11

(1)      These awards vest as to 25% of the total awards granted on each of the first four anniversaries of the applicable vesting commencement date, subject to the applicable recipient’s continued service through the applicable vesting date.

(2)      The vesting commencement date for RSUs granted on September 9, 2024 is June 6, 2024. Per ASC 718-10-35-2, compensation cost for an award of share-based compensation is recognized over the requisite service period. The service period for these awards begins on grant date. The Company considered the requirement in ASC 718-10-35-8 when recognizing current period expense.